Paul Azimov, DO
Physical Medicine & Rehabilitation · Springfield, MANPI 1447207139
Payments from drug & device makers
Across 24 payments — averaging $20.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$319
- Vertex$42
- SPR Therapeutics, Inc$41
- Scilex Pharmaceuticals Inc.$32
- Boston Scientific$22
- IBSA Pharma Inc.$18
- plus $16 from 1 others
What the payments were for
- Food & beverage$491100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 15 | $319 |
| Vertex | 2 | $42 |
| SPR Therapeutics, Inc | 2 | $41 |
| Scilex Pharmaceuticals Inc. | 2 | $32 |
| Boston Scientific | 1 | $22 |
| IBSA Pharma Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$491 in reported general payments places this provider in the 70th percentile of 244 physical medicine & rehabilitation providers in Massachusetts.
See all physical medicine & rehabilitation providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 150 | $160,528 |
| Buprenorphine | 161 | $44,229 |
| Xtampza ErOxycodone Myristate | 13 | $21,143 |
| Lidocaine | 82 | $15,667 |
| Emgality SyringeGalcanezumab-Gnlm | 22 | $14,888 |
| SavellaMilnacipran Hcl | 24 | $12,070 |
| Emgality PenGalcanezumab-Gnlm | 14 | $9,587 |
| BelbucaBuprenorphine Hcl | 12 | $7,023 |
| ButransBuprenorphine | 11 | $5,646 |
| Gabapentin | 333 | $4,758 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 273 | $4,502 |
| Oxycodone Hcl | 266 | $3,900 |
| Pregabalin | 132 | $2,197 |
| Morphine Sulfate ErMorphine Sulfate | 73 | $1,954 |
| Diclofenac Sodium | 42 | $1,584 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Springfield
- Robert KaplanSpringfield$2K
- Mohammed MawlaSpringfield$2K
- Deepthi GantaSpringfield$2K
- Howard LedermanSpringfield$2K
- Zachary BohartBurlington$654K
- John KeelBoston$113K
- Marc van de RijnCharlestown$89K
- Sabrina PaganoniCharlestown$80K
- Edward PhillipsBoston$75K
- Walter SussmanWellesley$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.